Institutional members access full text with Ovid®

Share this article on:

Is there a SERM in your menopause toolkit?

Liu, James H. MD, NCMP


In the article “Is there a SERM in your menopause toolkit?” by James H. Liu, appearing in Menopause, volume 24, pages 320-321, the section Financial disclosure/conflict of interest was incorrect and should have appeared as follows:

Financial disclosure/conflicts of interest: Dr. Liu reports past consulting fees from Pfizer and Sermonix; current consultancy with Charter Venture Capital; and grants or grants pending from AbbVie and Allergan.

The publisher regrets the error.

Menopause. 24(6):717, June 2017.

doi: 10.1097/GME.0000000000000806
Clinical Corner: NAMS Practice Pearl

Over the past 3 decades, compounds called selective estrogen receptor modulators (SERMs) have been developed that block the estrogen receptor in some tissues (estrogen receptor antagonists) or stimulate the estrogen receptor in other tissues (estrogen receptor agonists). This Practice Pearl focuses on SERMs that clinicians can use for menopausal patients.

Case Western Reserve University School of Medicine, Cleveland, OH.

Accepted 12 October, 2016

© 2017 by The North American Menopause Society.